Primary care management of patients with liver disease

Includes discussion of TA337 on rifaximin-α for hepatic encephalopathy

Register at https://www.workcast.com/register?pak=4542784189666846&cpak=5081352557668651

This 1-hour Guidelines in Practice webinar will:

• communicate the key recommendations from the latest NICE guideline on the assessment and management of cirrhosis
• share advice on implementing the cirrhosis guideline in primary care
• provide guidance on the implementation of NICE Technology Appraisal 337 on rifaximin-α for preventing overt episodes of hepatic encephalopathy
• use case studies to highlight best clinical practice.

This webinar is intended for healthcare professionals working in the NHS.

Please download the flyer for more information.

_{This webinar has been commissioned and funded by Norgine Pharmaceuticals Limited and organised in partnership with Guidelines in Practice. Norgine Pharmaceuticals Limited has reviewed the scope of the webinar, worked with MGP Ltd to choose and commission speakers, and approved all materials related to the webinar. Norgine Pharmaceuticals Limited has paid the speaker honoraria. The views and opinions of the speakers are not necessarily those of Norgine Pharmaceuticals Limited, or Guidelines in Practice, its publisher, advisers, or advertisers. Prescribing information and adverse event reporting information can be found overleaf.}